X-Therma is a biotechnology firm that develops a convergent biopreservation platform to advance regenerative medicine.
X-Therma has raised $22.4M in total funding. The most recent round was Series B. The last funding was announced in March 2024.
X-Therma's investors include National Science Foundation, VU Venture Partners, JANSZKY GmbH, 2b AHEAD Ventures Fund, Graphene Ventures.
X-Therma is headquartered in Richmond, United States.
X-Therma is a biotechnology firm that develops a convergent biopreservation platform to advance regenerative medicine.
X-Therma is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"X-Therma — Funding & Investors." VCBacked, March 13, 2024, https://www.vcbacked.co/company/x-therma. Accessed July 31, 2026.
VCBacked. (2024). X-Therma — Funding & Investors. Retrieved July 31, 2026, from https://www.vcbacked.co/company/x-therma
{{cite web |title=X-Therma — Funding & Investors |url=https://www.vcbacked.co/company/x-therma |website=VCBacked |access-date=July 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated